SEC Form 4 · accession 0001387131-18-002392
Corindus Vascular Robotics, Inc. · CVRS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Louis A Cannon
Director
Period of report
May 24, 2018
Accepted (ET)
May 25, 2018 · 6:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528557
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF4,F1,F2 | May 24, 2018 | P | 10,000 | $0.8009 | A | 82,955 | D | |
| Common StockF5,F1,F6 | May 25, 2018 | P | 6,500 | $0.7697 | A | 89,455 | D | |
| Common StockF3 | holding | — | — | — | 7,557,436 | I | See Footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes 9,174 shares of common stock related to restricted stock units granted as part of the director's annual equity award in 2017 which provided for initial vesting of one-quarter of the granted units and subsequent quarterly vesting on December 22, 2017, March 22, 2018 and June 22, 2018, subject to the reporting person's continuous service with Corindus Vascular Robotics, Inc. through each such vesting date.
- F260,801 shares are held in Cardiac & Vascular Research Center 401k FBO Louis A. Cannon; the remaining shares are held directly.
- F3Consists of securities directly owned by BioStar Ventures III, L.P. Dr. Cannon is the founder and Senior Managing Director of BioStar Ventures III, L.P. and, as such, may be deemed to beneficially own the securities held of record by BioStar Ventures III, L.P. for purposes of Rule 16a-1(a). Dr. Cannon disclaims any beneficial ownership of the securities reported, except to the extent of any pecuniary interest therein.
- F4The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.8002 to $0.805, inclusive. The reporting person undertakes to provide to Corindus Vascular Robotics, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- F5The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.7694 to $0.77, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- F667,301 shares are held in Cardiac & Vascular Research Center 401k FBO Louis A. Cannon; the remaining shares are held directly.